188 related articles for article (PubMed ID: 10097067)
1. A cytosine analog that confers enhanced potency to antisense oligonucleotides.
Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression.
McKay RA; Miraglia LJ; Cummins LL; Owens SR; Sasmor H; Dean NM
J Biol Chem; 1999 Jan; 274(3):1715-22. PubMed ID: 9880552
[TBL] [Abstract][Full Text] [Related]
3. Cellular penetration and antisense activity by a phenoxazine-substituted heptanucleotide.
Flanagan WM; Wagner RW; Grant D; Lin KY; Matteucci MD
Nat Biotechnol; 1999 Jan; 17(1):48-52. PubMed ID: 9920268
[TBL] [Abstract][Full Text] [Related]
4. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
[TBL] [Abstract][Full Text] [Related]
6. Streptogramin- and tetracycline-responsive dual regulated expression of p27(Kip1) sense and antisense enables positive and negative growth control of Chinese hamster ovary cells.
Fux C; Moser S; Schlatter S; Rimann M; Bailey JE; Fussenegger M
Nucleic Acids Res; 2001 Feb; 29(4):E19. PubMed ID: 11160939
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of oligonucleotide inhibitors of DNA (Cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites.
Güimil García R; Brank AS; Christman JK; Marquez VE; Eritja R
Antisense Nucleic Acid Drug Dev; 2001 Dec; 11(6):369-78. PubMed ID: 11838638
[TBL] [Abstract][Full Text] [Related]
8. Effects of oligonucleotide length, mismatches and mRNA levels on C-5 propyne-modified antisense potency.
Flanagan WM; Kothavale A; Wagner RW
Nucleic Acids Res; 1996 Aug; 24(15):2936-41. PubMed ID: 8760877
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
Flanagan WM; Su LL; Wagner RW
Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
[TBL] [Abstract][Full Text] [Related]
11. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
12. Rational selection of antisense oligonucleotide sequences.
Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
[TBL] [Abstract][Full Text] [Related]
13. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
[TBL] [Abstract][Full Text] [Related]
14. Sequence dependence of C5-propynyl-dU,dC-phosphorothioate oligonucleotide inhibition of the human IGF-I receptor: mRNA, protein, and cell growth.
Fogarty RD; McKean SC; White PJ; Atley LM; Werther GA; Wraight CJ
Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):369-77. PubMed ID: 12568311
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
Taipale M; Tiihonen E; Heiskanen A; Laiho M
Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
[TBL] [Abstract][Full Text] [Related]
16. Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression.
Uhlmann E; Peyman A; Ryte A; Schmidt A; Buddecke E
Methods Enzymol; 2000; 313():268-84. PubMed ID: 10595361
[No Abstract] [Full Text] [Related]
17. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
18. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.
Wahlestedt C; Salmi P; Good L; Kela J; Johnsson T; Hökfelt T; Broberger C; Porreca F; Lai J; Ren K; Ossipov M; Koshkin A; Jakobsen N; Skouv J; Oerum H; Jacobsen MH; Wengel J
Proc Natl Acad Sci U S A; 2000 May; 97(10):5633-8. PubMed ID: 10805816
[TBL] [Abstract][Full Text] [Related]
19. [Detection of p27/kip1 mRNA in blood cells by nonradioactive ribonuclease protection assay].
Okamoto Y; Nakabayashi H; Kikukawa S; Nakano H
Rinsho Byori; 1996 May; 44(5):483-6. PubMed ID: 8676570
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
